Daniel O'Connor

Daniel O'Connor is the EVP of Biologics & Corporate Development at Eagle Pharmaceuticals. Daniel has over 15 years of experience in the finance and accounting industry.

O'Connor started their career as a Sr. Financial Analyst at Ethicon in 2005. Daniel then became the Finance Manager at Eagle Pharmaceuticals in 2007. In 2011, they were promoted to Finance Director. Daniel served as Interim Chief Financial Officer from 2013 to 2014.

In their current role, O'Connor is responsible for leading the company's biologics and corporate development initiatives. Daniel also oversees the finance activities of the company, including venture debt, equity offerings, and stock / option valuation.

Daniel O'Connor has a MBA in Finance & Marketing from Rutgers University - Newark and a Bachelor of Science in Finance from West Virginia University. Daniel also attended Brick Township High School.

Daniel O'Connor reports to Scott Tarriff, Founder & CEO. They work with Brian Cahill - Chief Financial Officer, Michael Moran - EVP, Chief Commercial Officer, and John Kimmet - EVP, Marketing for Oncology & Acute Care.